ALEMBIC PHARMACEUTICALS
|
ALEMBIC PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
Sales | ₹6,112 Cr | ₹5,500 Cr | ₹5,232 Cr | ₹5,276 Cr | ₹4,492 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹12 Cr | ₹25 Cr | ₹15 Cr | ₹18 Cr | ₹21 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹104 Cr | ₹128 Cr | ₹59 Cr | ₹99 Cr | ₹93 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-143 Cr | ₹79 Cr | ₹-43 Cr | ₹-194 Cr | ₹-211 Cr |
Raw Material Consumed | ₹1,858 Cr | ₹1,630 Cr | ₹1,490 Cr | ₹1,451 Cr | ₹1,250 Cr |
Opening Raw Materials | ₹390 Cr | ₹456 Cr | ₹443 Cr | ₹294 Cr | ₹300 Cr |
Purchases Raw Materials | ₹1,399 Cr | ₹1,184 Cr | ₹1,203 Cr | ₹1,276 Cr | ₹973 Cr |
Closing Raw Materials | ₹386 Cr | ₹390 Cr | ₹517 Cr | ₹384 Cr | ₹294 Cr |
Other Direct Purchases / Brought in cost | ₹455 Cr | ₹380 Cr | ₹361 Cr | ₹266 Cr | ₹271 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹173 Cr | ₹152 Cr | ₹121 Cr | ₹119 Cr | ₹102 Cr |
Electricity & Power | ₹173 Cr | ₹152 Cr | ₹121 Cr | ₹119 Cr | ₹102 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,446 Cr | ₹1,169 Cr | ₹1,133 Cr | ₹1,051 Cr | ₹906 Cr |
Salaries, Wages & Bonus | ₹1,330 Cr | ₹1,072 Cr | ₹1,045 Cr | ₹966 Cr | ₹832 Cr |
Contributions to EPF & Pension Funds | ₹81 Cr | ₹68 Cr | ₹60 Cr | ₹54 Cr | ₹51 Cr |
Workmen and Staff Welfare Expenses | ₹35 Cr | ₹29 Cr | ₹28 Cr | ₹31 Cr | ₹24 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹388 Cr | ₹409 Cr | ₹379 Cr | ₹372 Cr | ₹368 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹68 Cr | ₹51 Cr | ₹19 Cr | ₹22 Cr | ₹18 Cr |
Repairs and Maintenance | ₹81 Cr | ₹66 Cr | ₹52 Cr | ₹83 Cr | ₹51 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹238 Cr | ₹293 Cr | ₹308 Cr | ₹267 Cr | ₹300 Cr |
General and Administration Expenses | ₹526 Cr | ₹493 Cr | ₹414 Cr | ₹391 Cr | ₹340 Cr |
Rent , Rates & Taxes | ₹18 Cr | ₹17 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr |
Insurance | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹13 Cr | ₹7.50 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹199 Cr | ₹210 Cr | ₹191 Cr | ₹198 Cr | ₹147 Cr |
Traveling and conveyance | ₹202 Cr | ₹171 Cr | ₹126 Cr | ₹108 Cr | ₹132 Cr |
Other Administration | ₹86 Cr | ₹75 Cr | ₹64 Cr | ₹59 Cr | ₹38 Cr |
Selling and Distribution Expenses | ₹997 Cr | ₹952 Cr | ₹890 Cr | ₹687 Cr | ₹531 Cr |
Advertisement & Sales Promotion | ₹733 Cr | ₹681 Cr | ₹634 Cr | ₹502 Cr | ₹398 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹264 Cr | ₹271 Cr | ₹256 Cr | ₹186 Cr | ₹133 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹51 Cr | ₹61 Cr | ₹48 Cr | ₹35 Cr | ₹104 Cr |
Bad debts /advances written off | ₹2.86 Cr | ₹6.35 Cr | ₹5.24 Cr | ₹0.19 Cr | ₹0.48 Cr |
Provision for doubtful debts | ₹5.36 Cr | - | ₹7.30 Cr | ₹6.06 Cr | ₹8.55 Cr |
Losson disposal of fixed assets(net) | - | ₹4.70 Cr | - | - | - |
Losson foreign exchange fluctuations | - | ₹0.09 Cr | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹43 Cr | ₹50 Cr | ₹35 Cr | ₹29 Cr | ₹95 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹5,296 Cr | ₹4,945 Cr | ₹4,432 Cr | ₹3,913 Cr | ₹3,392 Cr |
Operating Profit (Excl OI) | ₹933 Cr | ₹708 Cr | ₹874 Cr | ₹1,480 Cr | ₹1,214 Cr |
Other Income | ₹29 Cr | ₹3.04 Cr | ₹50 Cr | ₹87 Cr | ₹14 Cr |
Interest Received | ₹2.09 Cr | ₹0.33 Cr | ₹1.73 Cr | ₹1.58 Cr | ₹1.73 Cr |
Dividend Received | ₹0.01 Cr | - | - | - | ₹0.01 Cr |
Profit on sale of Fixed Assets | ₹1.70 Cr | - | ₹0.54 Cr | ₹1.39 Cr | ₹1.16 Cr |
Profits on sale of Investments | ₹1.63 Cr | ₹0.61 Cr | ₹2.87 Cr | ₹4.95 Cr | ₹0.92 Cr |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹18 Cr | - | ₹44 Cr | ₹77 Cr | ₹8.46 Cr |
Others | ₹5.92 Cr | ₹2.10 Cr | ₹1.04 Cr | ₹2.28 Cr | ₹1.60 Cr |
Operating Profit | ₹962 Cr | ₹711 Cr | ₹925 Cr | ₹1,568 Cr | ₹1,228 Cr |
Interest | ₹56 Cr | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹56 Cr | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr |
PBDT | ₹905 Cr | ₹661 Cr | ₹907 Cr | ₹1,552 Cr | ₹1,201 Cr |
Depreciation | ₹273 Cr | ₹275 Cr | ₹287 Cr | ₹183 Cr | ₹157 Cr |
Profit Before Taxation & Exceptional Items | ₹633 Cr | ₹386 Cr | ₹620 Cr | ₹1,368 Cr | ₹1,043 Cr |
Exceptional Income / Expenses | - | - | - | - | ₹-44 Cr |
Profit Before Tax | ₹632 Cr | ₹355 Cr | ₹625 Cr | ₹1,368 Cr | ₹1,000 Cr |
Provision for Tax | ₹16 Cr | ₹13 Cr | ₹104 Cr | ₹253 Cr | ₹199 Cr |
Current Income Tax | ₹66 Cr | ₹4.20 Cr | ₹129 Cr | ₹255 Cr | ₹205 Cr |
Deferred Tax | ₹-46 Cr | ₹9.20 Cr | ₹-23 Cr | ₹-9.56 Cr | ₹-4.30 Cr |
Other taxes | ₹-3.74 Cr | ₹-0.80 Cr | ₹-1.25 Cr | ₹7.41 Cr | ₹-1.09 Cr |
Profit After Tax | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,115 Cr | ₹801 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | ₹28 Cr |
Share of Associate | - | - | - | ₹32 Cr | ₹0.06 Cr |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,147 Cr | ₹829 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹3,568 Cr | ₹2,554 Cr | ₹2,385 Cr | ₹1,559 Cr | ₹1,287 Cr |
Appropriations | ₹4,184 Cr | ₹2,896 Cr | ₹2,906 Cr | ₹2,706 Cr | ₹2,116 Cr |
General Reserves | - | ₹-869 Cr | - | ₹250 Cr | ₹200 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹12 Cr |
Other Appropriation | ₹157 Cr | ₹197 Cr | ₹351 Cr | ₹71 Cr | ₹176 Cr |
Equity Dividend % | ₹550.00 | ₹400.00 | ₹500.00 | ₹700.00 | ₹500.00 |
Earnings Per Share | ₹31.33 | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 |
Adjusted EPS | ₹31.33 | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 |
Compare Income Statement of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹20,891.7 Cr | -0.2% | -2.2% | 32.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,145.0 Cr | -2% | 2.1% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,280.0 Cr | -3.5% | -3.4% | 49.9% | Stock Analytics | |
CIPLA | ₹120,379.0 Cr | -2.6% | -0.6% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | -2.7% | 8.9% | 14.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,774.5 Cr | -1% | -1.7% | 36.9% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -0.2% |
-2.2% |
32.8% |
SENSEX | -0.4% |
-3.7% |
7.9% |
You may also like the below Video Courses